On April 12, 2021, a total 26.4 million shares, representing almost 4% of the total number of Antibiotice Iasi shares, changed the shareholders in two special deals worth RON13.5 million, at a price higher by 2% than the market price.
Per stock market data, SIF Oltenia has an ownership of 19% in Antibiotice Iasi, which means the difference of 4% represents the special deal of April 12.
Per calculations by Ziarul Financiar based on stock market data, SIF Oltenia’s investment in Antibiotice Iasi reached RON77.4 million.
Antibiotice Iasi’s sales revenue dropped 12% on the year, to RON340 million, in 2020, and its net profit dropped 16% to RON25 million, against the backdrop of the sanitary crisis, which kept hospitals closed or operated for COVID-19 patients alone.
Antibiotice Iasi, with a market capitalization of RON332 million, is 53% owned by the Romanian State and 19% held by SIF Oltenia. ATB shares have been trading up 5.4% since the beginning of 2021, amid deals worth RON18.8 million, stock market data showed.